College Park Rehabilitation Center | |
2856 E. Cheyenne Ave., College Park, Nevada 89030 | |
(702) 644-1888 | |
Name | College Park Rehabilitation Center |
---|---|
Location | 2856 E. Cheyenne Ave., College Park, Nevada |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 188 |
Occupancy Rate | 44.2% |
Medicare ID (CCN) | 295055 |
Legal Business Name | Thi Of Nevada At Cheyenne, Llc |
Ownership Type | For Profit - Corporation |
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
People with social anxiety avoid situations in which they are exposed to judgment by others. Those affected also lead a withdrawn life and maintain contact above all on the Internet.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) has notified the Company that its new biologic license application (BLA) for ocriplasmin intravitreal injection will be discussed at the Dermatologic and Ophthalmic Drugs Advisory Committee scheduled for July 26, 2012.
Stephen L. Boehm II, Ph.D., associate professor of psychology in the School of Science at Indiana University-Purdue University Indianapolis, has been named the 2011 Young Scientist of the Year by the International Behavioural and Neural Genetics Society. The award will be presented May 13 at the society's annual meeting in Rome, Italy.
Researchers have found that some soups have antimalarial properties and can interrupt the life cycle of a malarial parasite.
Asynt announces how new scientific evaluations from the Department of Chemistry, University of Uppsala (Sweden) and the Australian National University (Canberra) report on the testing of the performance of their CondenSyn air condenser versus traditional water-driven condensers and an alternative commercial air condenser in "real-world" laboratory conditions.
› Verified 2 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 17.99 | 14.46 |
Percentage of long-stay residents who lose too much weight | 8.92 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 35.82 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 5.81 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 21.69 | 5.05 |
Percentage of long-stay residents who were physically restrained | 1.39 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.31 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 11.11 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 89.92 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 5.63 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 19.27 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 17.79 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 13.15 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.56 | 95.98 |
Percentage of short-stay residents who made improvements in function | 54.22 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 91.53 | 82.93 |
News Archive
People with social anxiety avoid situations in which they are exposed to judgment by others. Those affected also lead a withdrawn life and maintain contact above all on the Internet.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) has notified the Company that its new biologic license application (BLA) for ocriplasmin intravitreal injection will be discussed at the Dermatologic and Ophthalmic Drugs Advisory Committee scheduled for July 26, 2012.
Stephen L. Boehm II, Ph.D., associate professor of psychology in the School of Science at Indiana University-Purdue University Indianapolis, has been named the 2011 Young Scientist of the Year by the International Behavioural and Neural Genetics Society. The award will be presented May 13 at the society's annual meeting in Rome, Italy.
Researchers have found that some soups have antimalarial properties and can interrupt the life cycle of a malarial parasite.
Asynt announces how new scientific evaluations from the Department of Chemistry, University of Uppsala (Sweden) and the Australian National University (Canberra) report on the testing of the performance of their CondenSyn air condenser versus traditional water-driven condensers and an alternative commercial air condenser in "real-world" laboratory conditions.
› Verified 2 days ago
College Park Rehabilitation Center Location: 2856 E. Cheyenne Ave., College Park, Nevada 89030 Phone: (702) 644-1888 |